CytoDyn Income Statement (2010-2026) | CYDY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	May2021	Aug2021	Nov2021	Feb2022	May2022	Aug2022	Nov2022	Feb2023	May2023	Aug2023	Nov2023	Feb2024	May2024	Aug2024	Nov2024	Feb2025	May2025	Aug2025	Nov2025	Feb2026
Revenue & cost
Revenue (Quarter)		0.04M	0.23M		0.03M
Gross Profit (Quarter)		0.04M	0.17M
Operating items
Amortization - Deferred Charges (Quarter)
Research & Development (Quarter)	9.34M	12.02M	7.45M	3.57M	4.01M	0.58M	0.14M	0.94M	0.98M	1.91M	1.08M	0.65M	3.60M
Selling, General & Administrative (Quarter)	8.99M	7.62M	16.20M	10.14M	10.34M	6.33M	5.04M	2.97M	2.79M	2.69M	2.31M	2.76M	3.06M	1.61M	2.30M	1.52M	1.84M	1.71M	1.80M	1.65M
Other Operating Expenses (Quarter)	5.30M	-1.94M		5.69M	64.70M	2.80M	17.98M	0.01M	0.01M	0.01M	0.01M	0.01M	-0.03M	-24.05M	1.41M	2.49M	3.23M	3.23M	19.89M	4.65M
Operating Expenses (Quarter)	23.64M	21.68M	25.50M	19.40M	79.05M	9.71M	23.16M	3.92M	3.78M	4.61M	3.40M	3.41M	6.63M	-22.44M	3.71M	4.00M	5.07M	4.95M	21.69M	6.30M
Operating Income (Quarter)	-23.64M	-21.64M	-25.32M	-19.40M	-79.05M	-9.71M	-23.16M	-3.92M	-3.78M	-4.61M	-3.40M	-3.41M	-6.63M	22.44M	-3.71M	-4.00M	-5.07M	-4.95M	-21.69M	-6.30M
EBIT (Quarter)	-23.64M	-21.64M	-25.32M	-19.40M	-79.05M	-9.71M	-23.16M	-3.92M	-3.78M	-4.61M	-3.40M	-3.41M	-6.63M	22.44M	-3.71M	-4.00M	-5.07M	-4.95M	-21.69M	-6.30M
Non-operating items
Interest & Investment Income (Quarter)														0.13M	0.14M	0.17M	0.12M	0.09M	0.06M	0.01M
Other Non Operating Income (Quarter)	-8.10M	-4.65M	-3.31M	-3.11M						-2.08M	-2.41M	-1.55M	-7.33M		0.08M	0.33M	-0.01M
Net income details
EBT (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-4.76M	-5.96M	-5.54M	-22.61M	-4.69M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-5.12M	-5.96M	-5.54M	-22.61M	-4.69M
Income from Continuing Operations (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-4.76M	-5.96M	-5.54M	-22.61M	-4.69M
Consolidated Net Income (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-4.76M	-5.96M	-5.54M	-22.61M	-4.69M
Income towards Parent Company (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-4.76M	-5.96M	-5.54M	-22.61M	-4.69M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-4.76M	-5.96M	-5.54M	-22.61M	-4.69M
Additional items
EPS (Basic) (Quarter)	-0.12	-0.07	-0.06	-59.35	-0.12	-0.03	-0.03	-0.02	-0.02	-0.01	-0.01	-0.01	-0.02	0.02	0.00	0.00	0.00	0.00	-0.02	0.00
EPS (Diluted) (Quarter)	-0.12	-0.07	-0.06	-59.35	-0.12	-0.03	-0.03	-0.02	-0.02	-0.01	-0.01	-0.01	-0.02	0.02	0.00	0.00	0.00	0.00	-0.02	0.00
Shares Outstanding (Quarter)	587.59M	632.60M	662.60M	0.70M	676.90M	787.86M	813.37M	832.22M	836.53M	923.59M	958.99M	982.21M	969.51M	1,135.04M	1,221.40M	1,228.26M	1,205.76M	1,252.55M	1,261.02M	1,275.18M
Shares Outstanding (Diluted) (Quarter)	587.59M	632.60M	662.60M	0.70M	676.90M	787.86M	813.37M	832.22M	836.53M	923.59M	958.99M	982.21M	969.51M	1,198.29M	1,221.40M	1,228.26M	1,242.92M	1,252.55M	1,261.02M	1,275.18M
EBITDA (Quarter)	-23.64M	-21.64M	-25.32M	-19.40M	-79.05M	-9.71M	-23.16M	-3.92M	-3.78M	-4.61M	-3.40M	-3.41M	-6.63M	22.44M	-3.71M	-4.00M	-5.07M	-4.95M	-21.69M	-6.30M
Interest Expenses (Quarter)	46.44M	23.70M	14.76M	21.89M	1.12M	11.28M	3.33M	9.78M	14.86M	1.20M	1.16M	1.15M	4.62M	1.17M	1.16M	1.14M	30.27M	3.04M	3.79M	1.79M
Tax Rate (Quarter)

Research Tools

Developers

CytoDyn Income Statement (2010-2026) | CYDY

Research Tools

Developers

CytoDyn Income Statement (2010-2026) | CYDY

Create an account

Sign In

Reset Password